Product Information
PITAVASTATIN 2 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.9865 per EA under NDC 00480363298. Its NADAC has been published 136 times since Jan 17, 2024.
FDA first approved this application on Feb 3, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.09 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480363298
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205932FDA Approved
2/3/2017
TE Code
AB
On Market Since
11/2/2023
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 2 MG TABLET has been published 136 times since Jan 17, 2024, and over the history we have for it it has declined 51.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9865 per EA |
|---|---|
| All-time high | $2.4472 (Apr 10, 2024) |
| All-time low | $0.9865 (Aug 19, 2026) |
| 52-week high | $1.4992 |
| 52-week low | $0.9865 |
| Median price | $1.4814 |
| Average price | $1.5464 |
| Largest weekly change | -32.5% (Nov 20, 2024) |
| Weeks tracked | 136 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PITAVASTATIN 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 2 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.9865 per EA (NDC 00480363298), effective Aug 19, 2026.
How has the price of PITAVASTATIN 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 2 MG TABLET has declined 51.8%. It has been tracked across 136 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 2 MG TABLET?
Since Jan 17, 2024, the NADAC for PITAVASTATIN 2 MG TABLET has ranged from a low of $0.9865 (Aug 19, 2026) to a high of $2.4472 (Apr 10, 2024), with a median of $1.4814 per EA.
Are there cheaper alternatives to PITAVASTATIN 2 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PITAVASTATIN 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PITAVASTATIN 2 MG TABLET?
PITAVASTATIN 2 MG TABLET (NDC 00480363298) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.